Log in to save to my catalogue

Whole-Body Distribution of Donepezil as an Acetylcholinesterase Inhibitor after Oral Administration...

Whole-Body Distribution of Donepezil as an Acetylcholinesterase Inhibitor after Oral Administration...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8fdc77f1ffc647078ab27025ca0772a8

Whole-Body Distribution of Donepezil as an Acetylcholinesterase Inhibitor after Oral Administration in Normal Human Subjects: A 11C-donepezil PET Study

About this item

Full title

Whole-Body Distribution of Donepezil as an Acetylcholinesterase Inhibitor after Oral Administration in Normal Human Subjects: A 11C-donepezil PET Study

Publisher

Mashhad: Asia Oceania Journal of Nuclear Medicine & Biology

Journal title

Asia oceania journal of nuclear medicine and biology, 2017-01, Vol.5 (1), p.3-9

Language

Formats

Publication information

Publisher

Mashhad: Asia Oceania Journal of Nuclear Medicine & Biology

More information

Scope and Contents

Contents

Objective(s):It is difficult to investigate the whole-body distribution of an orally administered drug by means of positron emission tomography (PET), owing to the short physical half-life of radionuclides, especially when 11C-labeled compounds are tested. Therefore, we aimed to examine the whole-body distribution of donepezil (DNP) as an acetylcho...

Alternative Titles

Full title

Whole-Body Distribution of Donepezil as an Acetylcholinesterase Inhibitor after Oral Administration in Normal Human Subjects: A 11C-donepezil PET Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8fdc77f1ffc647078ab27025ca0772a8

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8fdc77f1ffc647078ab27025ca0772a8

Other Identifiers

ISSN

2322-5718

E-ISSN

2322-5726

DOI

10.22038/aojnmb.2016.7513

How to access this item